Fieldview Capital Management’s Viking Therapeutics VKTX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2025 Q1	–	Sell	-37,013	Closed	-$1.49M	–	601
2024 Q4	$1.49M	Buy	+37,013	New	+$1.49M	0.23%	131